Key facts
- This page summarizes Lisa Wright's Form 4 filing for Vericel Corp (VCEL).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 05 May 2023, 16:05.
Lisa Wright - 03 May 2023 Form 4 Insider Report for Vericel Corp (VCEL)
- Reporting relationship
- Director
- Issuer ticker
- VCEL
- Reported as of
- 03 May 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 May 2023, 16:05:00 UTC
- Prior SEC filing
- 28 Apr 2023
- Next SEC filing
- 02 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sean Flynn, as Attorney-in-Fact for Lisa Wright
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Lisa Wright filed Form 4 for Vericel Corp (VCEL) on 05 May 2023.
Change
- Previous filing in this sequence was filed on 28 Apr 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VCEL
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +8,000
- Change %
- Price
- $0.000000
- Shares after
- 8,000
- Date
- 03 May 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,000
- Exercise price
- $32.12
- Footnotes
- F1
VCEL
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +3,200
- Change %
- Price
- $0.000000
- Shares after
- 3,200
- Date
- 03 May 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,200
- Exercise price
- Footnotes
- F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company.
Footnote F2
Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
Footnote F3
These RSUs vest 100% on the earlier of May 3, 2024 or the date of the first Annual Meeting of Stockholders following May 3, 2023.
Footnote F4
No expiration date for this type of award.